Keorochana Gun, Pairuchvej Saran, Setrkraising Kittipong, Arirachakaran Alisara, Kongtharvonskul Jatupon
Orthopedics Department, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Orthopedics Department, Queen Savang Vadhana Memorial Hospital, Chon Buri, Thailand.
World Neurosurg. 2018 Nov;119:e244-e249. doi: 10.1016/j.wneu.2018.07.122. Epub 2018 Jul 27.
To assess postoperative outcomes and complications after percutaneous endoscopic lumbar discectomy (PELD) with or without epidural steroids (ES) administration in lumbar disc herniation.
In a double-blind randomized, placebo-controlled trial at Ramathibodi Hospital, Mahidol University, from May 2014 to May 2015, 30 patients were randomly allocated to receive ES or placebo (saline) after PELD. The primary outcome was 24-hour morphine consumption. Secondary outcomes were visual analog scale (VAS) scores for leg and back pain, Oswestry Disability Index score, Roland-Morris Disability Questionnaire score, and complications at 6-month follow-up.
Mean patient age was 60.0 years, and 0.57% of patients were male. Mean VAS back pain, VAS leg pain, Oswestry Disability Index, and Roland-Morris Disability Questionnaire scores at baseline were 4.7, 6.1, 24.9, 17.5 in the ES group and 5.1, 5.5, 24.7, 16.7 in the placebo group, respectively. Mean morphine requirements measured at 8, 16, and 24 hours were 3.47, 2.67, and <0.001 in the ES group and 3.13, 1.67, and 0.40 in the placebo group. The mean VAS scores measured at 4, 8, 12, 16, 20, and 24 hours were 2.99, 2.70, 2.56, 3.30, 3.05, and 2.05 the ES group and 3.13, 1.13, 1.26, 1.65, 1.22, and 1.08 in placebo group. The difference was not statistically significant (P > 0.05 for all).
Administration of ES with PELD for lumbar disc herniation does not improve postoperative pain, morphine requirements, or disability scores in the short-term and midterm periods.
评估在腰椎间盘突出症患者中,经皮内镜下腰椎间盘切除术(PELD)联合或不联合硬膜外类固醇(ES)给药后的术后结局及并发症。
在2014年5月至2015年5月于玛希隆大学拉玛提波迪医院进行的一项双盲随机、安慰剂对照试验中,30例患者在PELD术后被随机分配接受ES或安慰剂(生理盐水)。主要结局指标为24小时吗啡消耗量。次要结局指标包括腿部和背部疼痛的视觉模拟量表(VAS)评分、奥斯威斯功能障碍指数评分、罗兰-莫里斯残疾问卷评分以及6个月随访时的并发症情况。
患者平均年龄为60.0岁,男性占0.57%。ES组基线时的平均VAS背痛评分、VAS腿痛评分、奥斯威斯功能障碍指数评分和罗兰-莫里斯残疾问卷评分分别为4.7、6.1、24.9、17.5,安慰剂组分别为5.1、5.5、24.7、16.7。ES组在8小时、16小时和24小时测得的平均吗啡需求量分别为3.47、2.67和<0.001,安慰剂组分别为3.13、1.67和0.40。ES组在4小时、8小时、12小时、16小时、20小时和24小时测得的平均VAS评分分别为2.99、2.70、2.56、3.30、3.05和2.05,安慰剂组分别为3.13、1.13、1.26、1.65、1.22和1.08。差异无统计学意义(所有P>0.05)。
腰椎间盘突出症患者行PELD时联合使用ES在短期和中期内并不能改善术后疼痛、吗啡需求量或功能障碍评分。